NCT05222282 2023-09-28
Sexual Health in Patients With Hematologic Malignancies
Rigshospitalet, Denmark
Phase NA Unknown
Clinical Trials
9 trialsNCT01719432 2020-12-17
Effect of Body Mass on Filgrastim Pharmacokinetics
West Virginia University
Completed
NCT02696408 2020-01-29
STOP MUCITES
Institut de Cancérologie de la Loire
Phase 3 Completed
NCT03212560 2019-02-15
Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients
Gazi University
Completed
NCT01554254 2016-08-31
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
Tarix Pharmaceuticals
Phase 2 Withdrawn
NCT01882374 2016-08-31
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
Tarix Pharmaceuticals
Phase 2 Withdrawn
NCT01882387 2016-08-31
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Tarix Pharmaceuticals
Phase 2 Withdrawn
NCT01714180 2015-06-03
Effect of Body Mass on Acyclovir Pharmacokinetics
West Virginia University
Completed
NCT01732393 2012-12-05
Effect of Quercetin in Prevention and Treatment of Oral Mucositis
Mashhad University of Medical Sciences
Phase 1/2 Completed